Forxiga Tablets Specific Clinical Experience Investigation for Long-term Use
Status
Completed
Conditions
Type 2 Diabetes Mellitus
Details and patient eligibility
About
The purpose of the investigation is to confirm the following under the post-marketing actual use of Forxiga Tablets (hereinafter referred to as Forxiga)
- Development of ADRs specified as Key Investigation Items and the risk factors
- Contributing factors possibly having an impact on the safety and efficacy
- Development of ADRs unexpected from the Precautions for use and ADRs under actual drug use
Enrollment
7,793 patients
Sex
All
Volunteers
No Healthy Volunteers
Inclusion criteria
Patients treated with Forxiga for the first time due to type 2 diabetes mellitus, which is the indication of the drug.
Exclusion criteria
N/A
Trial contacts and locations
47
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems